Lightstone Ventures
Lightstone Ventures is a leading global venture capital firm.
Business Model:
Revenue: $14.6M
Employees: 51-200
Rankings
Detailed Lightstone Ventures Information
Geographic Data
Address: 485 Ramona St
City: Palo Alto
State: CA
Zip: 94301
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$847M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space.
Contact Phone:
+16503883676
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2019 | Cyteir Therapeutics | Series B | 40.2M |
| 7/2015 | Ra Pharmaceuticals | Series B | 58.5M |
| 1/2017 | Allay Therapeutics | Series A | 7M |
| 5/2019 | Locanabio | Series A | 55M |
| 9/2020 | Willow | Series C | 0 |
| 4/2014 | Earlens | Series B | 40M |
| 10/2017 | Claret Medical | Series C | 0 |
| 3/2023 | Relievant Medsystems | Series G | 0 |
| 2/2016 | Cala Health | Series B | 0 |
| 4/2016 | FIRE1 | Series B | 7.5M |
| 10/2017 | Gemini Therapeutics | Series A | 42.5M |
| 9/2019 | Bold Penguin | Series B | 32M |
| 3/2017 | ALX Oncology | Convertible Note | 25M |
| 6/2018 | Relievant Medsystems | Series E | 58M |
| 3/2015 | Nimbus Apollo | Series B | 43M |
| 3/2023 | Shoulder Innovations | Series D | 0 |
| 4/2020 | Cerevance | Series B | 65M |
| 4/2021 | WayCool | Series C | 0 |
| 1/2021 | Ligature Therapeutics | Seed Round | 0 |
| 3/2016 | Tizona Therapeutics | Series B | 43M |
| 10/2016 | Carrick Therapeutics | Series A | 95M |
| 1/2023 | Volta Medical | Series B | 0 |
| 3/2018 | Cyteir Therapeutics | Series B | 29M |
| 6/2023 | Tagworks Pharmaceuticals | Series A | 65M |
| 6/2023 | Tagworks Pharmaceuticals | Series A | 0 |
| 12/2020 | Locanabio | Series B | 0 |
| 9/2017 | Disarm Therapeutics | Series A | 30M |
| 12/2021 | Choiceform | Venture Round | 30M |
| 2/2019 | Nuvaira | Equity | 79M |
| 5/2017 | Cerevance | Series A | 5M |
| 11/2013 | Astria Therapeutics | Series B | 32.4M |
| 2/2020 | ALX Oncology | Series C | 105M |
| 2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
| 8/2014 | Claret Medical | Series B | 0 |
| 1/2019 | Allay Therapeutics | Series B | 25M |
| 4/2016 | Gemini Therapeutics | Seed Round | 2M |
| 8/2021 | Vigil Neuroscience | Series B | 0 |
| 3/2023 | FIRE1 | Venture Round | 0 |
| 9/2022 | Nimbus Therapeutics | Venture Round | 0 |
| 3/2015 | ALX Oncology | Series A | 36M |
| 10/2018 | Earlens | Series D | 0 |
| 12/2020 | Tallac Therapeutics | Series A | 62M |
| 11/2020 | Shoulder Innovations | Venture Round | 0 |
| 1/2014 | FIRE1 | Series A | - |
| 10/2015 | Elcelyx Therapeutics | Series E | 0 |
| 12/2019 | Willow | Series C | 20M |
| 2/2023 | Cerevance | Series B | 0 |
| 12/2016 | Cerevance | Series A | 21.5M |
| 5/2018 | Medisix Therapeutics | Series A | 20M |
| 12/2020 | Atsena Therapeutics | Series A | 0 |
| 10/2020 | Relievant Medsystems | Venture Round | 0 |
| 6/2017 | Earlens | Series C | 0 |
| 6/2018 | Nimbus Therapeutics | Series B | 65M |
| 11/2020 | Catamaran Bio | Series A | 0 |
| 2/2021 | Cyteir Therapeutics | Series C | 0 |
| 3/2015 | Nimbus Therapeutics | Series B | 43M |
| 6/2016 | Earlens | Series C | 0 |
| 1/2022 | ProVerum Medical | Series A | 0 |
| 1/2018 | FIRE1 | Series C | 49.6M |
| 4/2021 | Alchemab Therapeutics | Series A | 82.7M |
| 12/2022 | Carrick Therapeutics | Series C | 0 |
| 5/2019 | Cala Health | Series C | 0 |
| 9/2014 | Flex Pharma | Venture Round | 0 |
| 1/2022 | ProVerum Medical | Series A | 0 |
| 12/2021 | Choiceform | Venture Round | 0 |
| 8/2021 | Vigil Neuroscience | Series B | 0 |
| 4/2021 | Alchemab Therapeutics | Series A | 0 |
| 4/2021 | WayCool | Series C | 0 |
| 2/2021 | Cyteir Therapeutics | Series C | 0 |
| 2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
| 1/2021 | Ligature Therapeutics | Seed Round | 0 |
| 12/2020 | Atsena Therapeutics | Series A | 0 |
| 12/2020 | Locanabio | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
